Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions.
| Data(s) |
2010
|
|---|---|
| Resumo |
To study inflammatory reactions occurring in relation to demyelination, aggregating rat brain cell cultures were subjected to three different demyelinating insults, i.e., (i) lysophosphatidylcholine (LPC), (ii) interferon-gamma combined with lipopolysaccharide (IFN-gamma+LPS), and (iii) anti-MOG antibodies plus complement (alpha-MOG+C). Demyelination was assessed by measuring the expression of myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG), and the activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP). The accompanying inflammatory reactions were examined by the quantification of microglia-specific staining, by immunostaining for glial fibrillary acidic protein (GFAP), and by measuring the mRNA expression of a panel of inflammation-related genes. It was found that all three demyelinating insults decreased the expression of MBP and MOG, and induced microglial reactivity. LPC and alpha-MOG+C, but not IFN-gamma+LPS, decreased CNP activity; they also caused the appearance of macrophagic microglia, and increased GFAP staining indicating astrogliosis. LPC affected also the integrity of neurons and astrocytes. LPC and IFN-gamma+LPS upregulated the expression of the inflammation-related genes IL-6, TNF-alpha, Ccl5, Cxcl1, and iNOS, although to different degrees. Other inflammatory markers were upregulated by only one of the three insults, e.g., Cxcl2 by LPC; IL-1beta and IL-15 by IFN-gamma+LPS; and IFN-gamma by alpha-MOG+C. These findings indicate that each of the three demyelinating insults caused distinct patterns of demyelination and inflammatory reactivity, and that of the demyelinating agents tested only LPC exhibited general toxicity. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_50F1DC1455BD isbn:1872-6240 (Electronic) pmid:20638371 doi:10.1016/j.brainres.2010.07.016 isiid:000282419500022 |
| Idioma(s) |
en |
| Fonte |
Brain Research, vol. 1353, pp. 213-224 |
| Palavras-Chave | #2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism; Animals; Antibodies/pharmacology; Brain/cytology; Cells, Cultured; Choline O-Acetyltransferase/metabolism; Cytokines/genetics; Cytokines/metabolism; Demyelinating Diseases/metabolism; Demyelinating Diseases/physiopathology; Drug Interactions; Embryo, Mammalian; Glial Fibrillary Acidic Protein/genetics; Glial Fibrillary Acidic Protein/metabolism; Glutamate Decarboxylase/metabolism; Immunologic Factors/genetics; Immunologic Factors/metabolism; Interferon-gamma/pharmacology; Lectins/metabolism; Lysophosphatidylcholines/pharmacology; Myelin Basic Proteins/genetics; Myelin Basic Proteins/metabolism; Myelin-Associated Glycoprotein/immunology; Myelin-Associated Glycoprotein/metabolism; Neurons/drug effects; Neurons/metabolism; Polysaccharides/pharmacology; RNA, Messenger/metabolism; Rats; Tumor Necrosis Factor-alpha/metabolism; Up-Regulation/drug effects |
| Tipo |
info:eu-repo/semantics/article article |